FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2297000898> ?p ?o ?g. }

• W2297000898 endingPage "e000075" @default.
• W2297000898 startingPage "e000075" @default.
• W2297000898 abstract "<h3>Background</h3> Type-2 diabetes mellitus (T2DM) is a risk factor for progressive non-alcoholic fatty liver disease (NAFLD). Drugs commonly prescribed in patients with T2DM may affect liver histology by interfering with lipid metabolism and insulin resistance/secretion. <h3>Aim</h3> We studied if statins or antidiabetic agents were associated with non-alcoholic steatohepatitis (NASH) and significant fibrosis (SF). <h3>Methods</h3> We performed a cross-sectional study of 346 diabetics with biopsy-proven NAFLD. T2DM was defined as fasting glucose ≥7 mmol/L or glycated haemoglobin ≥6.5% and/or use of antidiabetics. NASH was defined according to the FLIP algorithm and SF as F2–4 Kleiner9s stages. <h3>Results</h3> 84% of patients were on antidiabetic therapy and 45% on statins. NASH and SF were present in 57% and 48% of patients. Statin-treated patients were older, more frequently male and with poorer glycaemic control despite more frequent antidiabetic therapy than those without statins; however, the prevalence of NASH (57%vs56%, p=0.868) and SF (48%vs48%, p=0.943) was not different between statin users and non-users. NASH was more common in patients on metformin or insulin than in those not treated with these drugs (60%vs47%, p=0.026; 68%vs53%, p=0.017). SF was more common in those treated with sulfonylureas (57%vs44%, p=0.030). Multivariate analyses confirmed that use of statins was independently and negatively associated with both NASH (OR (95% CI) 0.57 (0.32 to 1.01), p=0.055) and SF (OR (95% CI) 0.47 (0.26 to 0.84), p=0.011). Moreover, we found independent associations between insulin use and NASH (OR (95% CI) 2.24 (1.11 to 4.54), p=0.025) and sulfonylureas use and SF (OR (95% CI) 2.04 (1.11 to 3.74), p=0.022). <h3>Conclusions</h3> Several medications used in patients with diabetes are differently associated with NAFLD histology. Statin use is negatively associated, while insulin and sulfonylureas are positively associated with NASH and SF. A wider use of statins may be warranted in this high-risk population." @default.
• W2297000898 created "2016-06-24" @default.
• W2297000898 creator A5000462944 @default.
• W2297000898 creator A5000704666 @default.
• W2297000898 creator A5027224797 @default.
• W2297000898 creator A5038609111 @default.
• W2297000898 creator A5038989175 @default.
• W2297000898 creator A5041168553 @default.
• W2297000898 creator A5047247337 @default.
• W2297000898 creator A5072395263 @default.
• W2297000898 creator A5079384310 @default.
• W2297000898 creator A5083408547 @default.
• W2297000898 date "2016-03-01" @default.
• W2297000898 modified "2023-10-17" @default.
• W2297000898 title "Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease" @default.
• W2297000898 cites W1606178710 @default.
• W2297000898 cites W1964572117 @default.
• W2297000898 cites W1964873462 @default.
• W2297000898 cites W1965389059 @default.
• W2297000898 cites W1974885996 @default.
• W2297000898 cites W1980520860 @default.
• W2297000898 cites W2000545769 @default.
• W2297000898 cites W2004267786 @default.
• W2297000898 cites W2028705615 @default.
• W2297000898 cites W2039800528 @default.
• W2297000898 cites W2059201072 @default.
• W2297000898 cites W2063106327 @default.
• W2297000898 cites W2067740038 @default.
• W2297000898 cites W2073530393 @default.
• W2297000898 cites W2084461928 @default.
• W2297000898 cites W2086657341 @default.
• W2297000898 cites W2100093159 @default.
• W2297000898 cites W2120397203 @default.
• W2297000898 cites W2127375111 @default.
• W2297000898 cites W2128460332 @default.
• W2297000898 cites W2134247216 @default.
• W2297000898 cites W2136909828 @default.
• W2297000898 cites W2139654088 @default.
• W2297000898 cites W2142636360 @default.
• W2297000898 cites W2143104968 @default.
• W2297000898 cites W2157338541 @default.
• W2297000898 cites W2158373383 @default.
• W2297000898 cites W2202737485 @default.
• W2297000898 cites W2607031541 @default.
• W2297000898 cites W4241883936 @default.
• W2297000898 cites W4242364069 @default.
• W2297000898 cites W4244540230 @default.
• W2297000898 doi "https://doi.org/10.1136/bmjgast-2015-000075" @default.
• W2297000898 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4838660" @default.
• W2297000898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27110380" @default.
• W2297000898 hasPublicationYear "2016" @default.
• W2297000898 type Work @default.
• W2297000898 sameAs 2297000898 @default.
• W2297000898 citedByCount "84" @default.
• W2297000898 countsByYear W22970008982016 @default.
• W2297000898 countsByYear W22970008982017 @default.
• W2297000898 countsByYear W22970008982018 @default.
• W2297000898 countsByYear W22970008982019 @default.
• W2297000898 countsByYear W22970008982020 @default.
• W2297000898 countsByYear W22970008982021 @default.
• W2297000898 countsByYear W22970008982022 @default.
• W2297000898 countsByYear W22970008982023 @default.
• W2297000898 crossrefType "journal-article" @default.
• W2297000898 hasAuthorship W2297000898A5000462944 @default.
• W2297000898 hasAuthorship W2297000898A5000704666 @default.
• W2297000898 hasAuthorship W2297000898A5027224797 @default.
• W2297000898 hasAuthorship W2297000898A5038609111 @default.
• W2297000898 hasAuthorship W2297000898A5038989175 @default.
• W2297000898 hasAuthorship W2297000898A5041168553 @default.
• W2297000898 hasAuthorship W2297000898A5047247337 @default.
• W2297000898 hasAuthorship W2297000898A5072395263 @default.
• W2297000898 hasAuthorship W2297000898A5079384310 @default.
• W2297000898 hasAuthorship W2297000898A5083408547 @default.
• W2297000898 hasBestOaLocation W22970008981 @default.
• W2297000898 hasConcept C126322002 @default.
• W2297000898 hasConcept C134018914 @default.
• W2297000898 hasConcept C2775934546 @default.
• W2297000898 hasConcept C2776839432 @default.
• W2297000898 hasConcept C2777180221 @default.
• W2297000898 hasConcept C2777391703 @default.
• W2297000898 hasConcept C2777766500 @default.
• W2297000898 hasConcept C2778772119 @default.
• W2297000898 hasConcept C2779134260 @default.
• W2297000898 hasConcept C2779306644 @default.
• W2297000898 hasConcept C2779478299 @default.
• W2297000898 hasConcept C2780323712 @default.
• W2297000898 hasConcept C2910068830 @default.
• W2297000898 hasConcept C555293320 @default.
• W2297000898 hasConcept C71924100 @default.
• W2297000898 hasConcept C90924648 @default.
• W2297000898 hasConceptScore W2297000898C126322002 @default.
• W2297000898 hasConceptScore W2297000898C134018914 @default.
• W2297000898 hasConceptScore W2297000898C2775934546 @default.
• W2297000898 hasConceptScore W2297000898C2776839432 @default.
• W2297000898 hasConceptScore W2297000898C2777180221 @default.
• W2297000898 hasConceptScore W2297000898C2777391703 @default.
• W2297000898 hasConceptScore W2297000898C2777766500 @default.
• W2297000898 hasConceptScore W2297000898C2778772119 @default.

• next